CXCL1 and pancreatic ductal adenocarcinoma: It has been proven that CXCL1-promoted macrophage-induced adaptive immunosuppression can be induced by necroptosis to advance the occurrence of pancreatic ductal adenocarcinoma (Seifert et al., 2016).